Search results

Narrow your search

Result types

Showing 2421 - 2430 of 3131 for "Corporate and M&A" with applied filters

News & Analysis

LAWYER OF THE MONTH - FEBRUARY 2023

21 February 2023 by asialaw

asialaw's Lawyer of the Month for February 2023 is...

News & Analysis

DEAL OF THE MONTH - FEBRUARY 2023

21 February 2023 by asialaw

asialaw's Deal of the Month for February 2023 is...

News & Analysis

Anand and Anand launches ‘Digital Group’

20 February 2023 by Anand and Anand - India

In its centenary year, Tier I full-service Intellectual Property firm Anand and Anand today announced the launch of its ‘Digital Group’.

News & Analysis

Korean Tax Law and Regulation Updates for 2023

20 February 2023 by Lee & Ko - South Korea

Korea’s latest tax reforms package was approved by the National Assembly in December 2022, with further details made clear by the Presidential Enforcement Decree which was published in January 2023. Before going into the details of the Korean tax reforms for 2023, it is important to consider the wider global context and domestic political context in which these reforms have been made, in order to understand some of the rationale underlying the reforms.

News & Analysis

Opportunity to Avoid Abandonment of Trademark Applications

15 February 2023 by LexOrbis - Manisha Singh & Omesh Puri

The Office of the Controller General Patents, Designs and Trademarks, India issued two public notices dated February 06, 2023, to deal with trademark applications pending before all their offices and expedite their disposal. Both public notices deal with the prosecution of trademark applications that were pending for mandatory actions on behalf of the Applicants in respect of either filing response to the examination report or filing of counterstatement against a notice of opposition.

News & Analysis

SSEK Proudly Announces Brand Refresh

14 February 2023 by SSEK Legal Consultants

SSEK is pleased to announce a brand refresh including a redesign of the firm’s logo, website, and communications. We also have updated our name to SSEK Law Firm.

News & Analysis

Missed deadline: Remedy under the Indian Patent Laws

07 February 2023 by LexOrbis - Manisha Singh (Partner) & Krishna Goyal (Associate)

The process to obtain a patent entails multiple stages from the filing of a patent application to the grant of the patent. There are various deadlines associated with each of these stages, such as the date of filing an application for the grant of patent and the date of filing the Request for Examination (RFE). The Indian Patent Office is very stringent for adherence to these deadlines, and failure to meet them may result in the rejection of a patent application. Thus, it is very important for a patent professional or an Applicant to cautiously meet the to avoid any adverse effect on the application. This article covers the consequences and remedies under the Indian patent laws in case any deadline associated with the patent application is missed.

News & Analysis

Amendment to the Safe Harbor Standards Under the Guidelines for Examination of Unlawful Support

06 February 2023 by Jipyong - South Korea

Effective from December 9, 2022, the amended Guidelines for Examination of Unlawful Support (the “Guidelines”) expands the scope and modifies the standards of the existing safe harbor.

News & Analysis

Guideline on New Anti-money Laundering Law

05 February 2023 by VILAF - Vietnam

While Vietnam remains a predominantly cash-based economy, its legal frame work on anti-money laundering, according to the Asian Pacific Group on Money Laundering (APG)’s assessment in its Mutual Evaluation Report dated January 2022, is still incomprehensive and limited, which makes the country itself vulnerable to risks of money laundering.

News & Analysis

India: Contemnor to pay INR 2 Crores to the plaintiffs in a patent infringement case

02 February 2023 by Anand and Anand

Pfizer Inc. and its group companies (“Pfizer”) filed a suit bearing no. CS (COMM) No. 442 of 2021 titled as Pfizer Inc. & Ors. v. Triveni Interchem Private Limited & Ors. before the Hon’ble Delhi High Court, for infringement of patent IN 218291 for the compound Palbociclib.